Current and emerging treatments for vitiligo

Vitiligo Working Group

Research output: Contribution to journalReview article

33 Citations (Scopus)

Abstract

Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.

Original languageEnglish (US)
Pages (from-to)17-29
Number of pages13
JournalJournal of the American Academy of Dermatology
Volume77
Issue number1
DOIs
StatePublished - Jul 1 2017

Fingerprint

Vitiligo
Continuing Medical Education
Phototherapy
Therapeutics
Immunosuppressive Agents
Cosmetics
Disease Progression

Keywords

  • afamelanotide
  • biologics
  • corticosteroids
  • excimer lamp
  • excimer laser
  • grafting
  • leukoderma
  • methotrexate
  • narrowband ultraviolet light
  • phototherapy
  • pigmentation
  • tacrolimus
  • treatment
  • vitiligo

ASJC Scopus subject areas

  • Dermatology

Cite this

Current and emerging treatments for vitiligo. / Vitiligo Working Group.

In: Journal of the American Academy of Dermatology, Vol. 77, No. 1, 01.07.2017, p. 17-29.

Research output: Contribution to journalReview article

Vitiligo Working Group. / Current and emerging treatments for vitiligo. In: Journal of the American Academy of Dermatology. 2017 ; Vol. 77, No. 1. pp. 17-29.
@article{ff8ec82e43764e06903471811a8ceeac,
title = "Current and emerging treatments for vitiligo",
abstract = "Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.",
keywords = "afamelanotide, biologics, corticosteroids, excimer lamp, excimer laser, grafting, leukoderma, methotrexate, narrowband ultraviolet light, phototherapy, pigmentation, tacrolimus, treatment, vitiligo",
author = "{Vitiligo Working Group} and Michelle Rodrigues and Khaled Ezzedine and Iltefat Hamzavi and Pandya, {Amit G.} and Harris, {John E.}",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.jaad.2016.11.010",
language = "English (US)",
volume = "77",
pages = "17--29",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Current and emerging treatments for vitiligo

AU - Vitiligo Working Group

AU - Rodrigues, Michelle

AU - Ezzedine, Khaled

AU - Hamzavi, Iltefat

AU - Pandya, Amit G.

AU - Harris, John E.

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.

AB - Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.

KW - afamelanotide

KW - biologics

KW - corticosteroids

KW - excimer lamp

KW - excimer laser

KW - grafting

KW - leukoderma

KW - methotrexate

KW - narrowband ultraviolet light

KW - phototherapy

KW - pigmentation

KW - tacrolimus

KW - treatment

KW - vitiligo

UR - http://www.scopus.com/inward/record.url?scp=85020842498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020842498&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2016.11.010

DO - 10.1016/j.jaad.2016.11.010

M3 - Review article

C2 - 28619557

AN - SCOPUS:85020842498

VL - 77

SP - 17

EP - 29

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 1

ER -